RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 523.09B
Enterprise Value 324.22B
Trailing P/E 55.37
Forward P/E 135.60
PEG Ratio (5 yr expected) 11.92
Price/Sales (ttm)8.55
Price/Book (mrq)10.90
Enterprise Value/Revenue 38.97
Enterprise Value/EBITDA 629.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.42
52-Week Change 336.83%
S&P500 52-Week Change 325.98%
52 Week High 3161.98
52 Week Low 390.64
50-Day Moving Average 3154.65
200-Day Moving Average 3139.39

Share Statistics

Avg Vol (3 month) 3505.53k
Avg Vol (10 day) 3452.26k
Shares Outstanding 5143.79M
Float 142.38M
% Held by Insiders 10.81%
% Held by Institutions 170.76%
Shares Short (Dec. 30, 2019) 42.26M
Short Ratio (Dec. 30, 2019) 44.62
Short % of Float (Dec. 30, 2019) 41.76%
Short % of Shares Outstanding (Dec. 30, 2019) 41.57%
Shares Short (prior month Nov. 28, 2019) 42.31M

Dividends & Splits

Forward Annual Dividend Rate 41.56
Forward Annual Dividend Yield 40.97%
Trailing Annual Dividend Rate 31.52
Trailing Annual Dividend Yield 30.95%
5 Year Average Dividend Yield 41.64
Payout Ratio 451.72%
Dividend Date 3Dec. 11, 2019
Ex-Dividend Date 4Nov. 05, 2019
Last Split Factor 22:1
Last Split Date 3Aug. 30, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun. 29, 2019
Most Recent Quarter (mrq)Sep. 29, 2019


Profit Margin 15.52%
Operating Margin (ttm)24.56%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)20.86%

Income Statement

Revenue (ttm)2.7B
Revenue Per Share (ttm)18.83
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)1.54B
EBITDA 821.28M
Net Income Avi to Common (ttm)419M
Diluted EPS (ttm)2.90
Quarterly Earnings Growth (yoy)13.60%

Balance Sheet

Total Cash (mrq)172.15M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)1.31B
Total Debt/Equity (mrq)61.66
Current Ratio (mrq)2.11
Book Value Per Share (mrq)14.73

Cash Flow Statement

Operating Cash Flow (ttm)573.29M
Levered Free Cash Flow (ttm)496.76M